stockrowAlign Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.9%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
Follow ALGN
Alert me
Align Technology, Inc. (ALGN) Return on assets
Align Technology, Inc.'s return on assets over the twelve months to 30 September 2026 was 7.71%, up 1.1 percentage points from fiscal 2025 (6.59%). Over the past ten years it has ranged from 6.08% (fiscal 2022) to 48.5% (fiscal 2020); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 6.59% | (0.26) |
| FY2024 | 6.85% | (0.55) |
| FY2023 | 7.40% | 1.32 |
| FY2022 | 6.08% | (8.25) |
| FY2021 | 14.3% | (34.12) |
| FY2020 | 48.5% | 29.00 |
| FY2019 | 19.5% | (1.41) |
| FY2018 | 20.9% | 6.31 |
| FY2017 | 14.6% | (0.30) |
| FY2016 | 14.9% | 1.43 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| ALGN Align Technology, Inc. | 7.71% |
| ATR AptarGroup, Inc. compare | 5.23% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| AVTR Avantor, Inc. compare | 2.89% |
| SOLV Solventum Corporation compare | 1.11% |
| RGEN Repligen Corporation compare | −0.40% |
| BLCO Bausch + Lomb Corporation compare | −0.80% |
| BAX Baxter International Inc. compare | −3.57% |
| TFX Teleflex Incorporated compare | −14.6% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement